About eyeforpharma

eyeforpharma has, for the 5th year in a row, grown by over 50% in 2009.

What's behind this impressive rate? As always, the reasons are very simple. The eyeforpharma team spends most of its time concentrating on meeting the needs of pharmaceutical executives through extensive research. Every event undergoes a thorough process involving contributions from managers and directors from the inner ranks of big pharma and other important stakeholders.

We don't spend our time decorating hotels or providing golf days for executives. We'd much rather be known for the quality and commercial gains to be made from involving experts with relevant topics, knowledge and networking.

The pharmaceutical industry is facing a period of significant change and eyeforpharma aims to be there to support and guide with the most insightful knowledge available.

Some more facts from eyeforpharma in 2009.

• Pharma executive delegates up 41% in 2009.
• 96% repeat business from our sponsors between 2008 and 2009
• Newsletter subscribers up 33%
• eyeforpharma has doubled in size in the past 18 months. (and grown tenfold since 2003)
• Number of events to increase from 20 to 35+ in 2009
• eyeforpharma now runs successful events in the US, Europe, Japan, China, Latin America, South America, Middle East and, new for 2009, India.

Topics in 2011

• SFE (Sales Force Effectiveness)
  Our flagship event is now the leader in Europe, US, Japan, China, Russia, Latin America, South America and the Middle East. Sales executives everywhere are faced with difficult decisions and the threat of severe cuts if they can't deliver significant ROI in a saturated market. With a focus on sales strategy, training & development, integration with marketing departments, CRM and online strategies. New for 2009 includes new commercial models, launch strategies and dealing with patients and other healthcare organisations – not just physicians.
  
  Also new for 2009: two new events on Sales and Marketing in Medical Devices & Diagnostics.
• Marketing
  With sales force budgets falling, marketing will really come into its own throughout 2010. A renewed effort towards ROI, eMarketing, Multiple Channels and Multiple Stakeholders as well as the continued improvements in analysis and branding science will all feature in our marketing events, which now take place in Europe, Japan, Latin America, Russia and China.
• eMarketing
  The importance of social networks, Web 2.0 and eMarketing is nothing new. In fact, it has become a standard and crucial part of any successful marketing mix and pharma is putting a particularly strong emphasis on the efficiencies which can be gained through successful use of new technologies for marketing. This event focuses on the cutting-edge and the new. It is for forward-thinking experts who are pushing pharmaceutical marketing to new levels. Are you one of these market drivers?
• Forecasting
  The importance of forecasting grows as margins tighten. Strategic and demand forecasting, particularly for new territories and new products, are important topics addressed at this event. Absolutely vital for General managers, Forecasters, Market Researchers and anybody who wants to reduce risk in their planning processes.
• Patient Compliance
  2009 saw a renewed energy in most major pharma companies to put the patient at the centre of the value chart. New strategies for patient compliance, adherence, communication and education will be strong differentiators for several years to come. The gains are huge if you can get it right, but the challenges are significant.
• Business Intelligence
  Pharma companies seeking competitive advantage are now relying on BI as an innovation and decision-making driver. The aim is to transform insight into action, make decisions quickly and capitalize on opportunities more fully. Competitive Intelligence, New Product Planning, Internal Communication and Market Analysis are all key topics covered here.
• Market Access and Health Technology Assessment
  As western economies suffer risks of recession and governments find ways to reduce spending, proving the value and efficacy of drugs at launch stage and even in mature stages of the lifecycle becomes more important. Meeting and exceeding new restrictions and requirements is becoming one of the most essential skills of the modern pharma company, a skill explored in detail at this event.
• Virtual R&D
  Drug Development and Trial costs are going only one way: upwards. Improvements in the virtual modelling of the human body, Open Innovation and of Web 2.0 technologies allowing collaboration and use of semantic searches in public research are just the tip of the iceberg when it comes to reducing costs across research departments.

Calendar of events 2011

For full event information, visit www.eyeforpharma.com

Get involved

Our events are popular because they are designed by pharma executives, for pharma executives. However, there are a small number of opportunities for you to get your company's message out – and improve the number of face-to-face relationships you have with decision makers.

For attending, speaking and/or programme:

Kunie Akahoshi
Global Event Director
Email: kakahoshi@eyeforpharma.com 


For sponsoring and exhibition opportunities or general inquiries about eyeforpharma Japan:

Takuya Shimada
Head of Japanese Business
Email: tshimada@eyeforpharma.com